FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

5032411000001100: Naropin 20mg/10ml solution for injection ampoules (AstraZeneca) 5 ampoule 5 x 10ml ampoules (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
27180901000001111 Naropin 20mg/10ml solution for injection ampoules (AstraZeneca) 5 ampoule 5 x 10ml ampoules (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
103461201000001110 Naropin 20mg/10ml solution for injection ampoules (Aspen Pharma Trading Ltd) 5 ampoule en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Naropin 20mg/10ml solution for injection ampoules (AstraZeneca) 5 ampoule 5 x 10ml ampoules Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Naropin 20mg/10ml solution for injection ampoules (AstraZeneca) 5 ampoule 5 x 10ml ampoules Is a Ropivacaine 20mg/10ml solution for injection ampoules 5 ampoule true Inferred relationship Existential restriction modifier
Naropin 20mg/10ml solution for injection ampoules (AstraZeneca) 5 ampoule 5 x 10ml ampoules Is pack of Naropin 20mg/10ml solution for injection ampoules (AstraZeneca) false Inferred relationship Existential restriction modifier
Naropin 20mg/10ml solution for injection ampoules (AstraZeneca) 5 ampoule 5 x 10ml ampoules Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Naropin 20mg/10ml solution for injection ampoules (AstraZeneca) 5 ampoule 5 x 10ml ampoules Has active ingredient Ropivacaine hydrochloride false Inferred relationship Existential restriction modifier
Naropin 20mg/10ml solution for injection ampoules (AstraZeneca) 5 ampoule 5 x 10ml ampoules Has active ingredient Ropivacaine false Inferred relationship Existential restriction modifier
Naropin 20mg/10ml solution for injection ampoules (AstraZeneca) 5 ampoule 5 x 10ml ampoules Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Naropin 20mg/10ml solution for injection ampoules (AstraZeneca) 5 ampoule 5 x 10ml ampoules Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Naropin 20mg/10ml solution for injection ampoules (AstraZeneca) 5 ampoule 5 x 10ml ampoules Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Naropin 20mg/10ml solution for injection ampoules (AstraZeneca) 5 ampoule 5 x 10ml ampoules VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Naropin 20mg/10ml solution for injection ampoules (AstraZeneca) 5 ampoule 5 x 10ml ampoules VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Naropin 20mg/10ml solution for injection ampoules (AstraZeneca) 5 ampoule 5 x 10ml ampoules Has manufactured dose form Conventional release solution for injection false Inferred relationship Existential restriction modifier
Naropin 20mg/10ml solution for injection ampoules (AstraZeneca) 5 ampoule 5 x 10ml ampoules Has AMP Naropin 20mg/10ml solution for injection ampoules (AstraZeneca) true Inferred relationship Existential restriction modifier
Naropin 20mg/10ml solution for injection ampoules (AstraZeneca) 5 ampoule 5 x 10ml ampoules Has specific active ingredient Ropivacaine hydrochloride true Inferred relationship Existential restriction modifier
Naropin 20mg/10ml solution for injection ampoules (AstraZeneca) 5 ampoule 5 x 10ml ampoules Has dispensed dose form Conventional release solution for injection true Inferred relationship Existential restriction modifier
Naropin 20mg/10ml solution for injection ampoules (AstraZeneca) 5 ampoule 5 x 10ml ampoules Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start